跳至主要内容
临床试验/JPRN-UMIN000014338
JPRN-UMIN000014338已完成未知

Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin) for intraocular neovascular disease and macular edema - Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin)

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine0 个研究点目标入组 3,000 人开始时间: 2014年6月25日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
3,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) The patient who has difficulty in observation of the fundus for high cataract, corneal clouding 2) Patient younger than 20 years 3) The patient who received other study medication or other clinical experimental medicine within three months before this medication start 4) In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject

研究者

发起方
Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine

相似试验